Determination of MDA as oxidative stress marker and most common type of blood group in asthmatic patients before and after treatment with montelukast drug.
Asthma is a complex chronic inflammatory disorder of airways characterized by airway smooth muscle hypertrophy, hyperplasia and over production of mucous in which many cells and cellular elements play an important role. The aim of the study is to monitor the changes in asthmatic patients before...
Saved in:
Main Authors: | Jwad Ali Saleh, Shakir Mahmoud Suleiman, Zaidan Jayed Zaidan |
---|---|
Format: | Article |
Language: | English |
Published: |
Tikrit University
2023-02-01
|
Series: | Tikrit Journal of Pure Science |
Subjects: | |
Online Access: | https://tjpsj.org/index.php/tjps/article/view/1164 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of Montelukast Sodium by flow injection chemiluminescence
by: Omar Adnan Hashem, et al.
Published: (2023-01-01) -
Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anticonvulsant properties
by: S.Yu. Shtrygol, et al.
Published: (2021-06-01) -
COST–EFFECTIVENESS ANALYSIS OF THE MONTELUKAST APPLICATION IN CHILDREN WITH BRONCHIAL ASTHM IN THE CONDITIONS OF THE REPUBLIC OF BELARUS HEALTH CARE SYSTEM
by: I. N. Kozhanova, et al.
Published: (2012-10-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 1
by: N. G. Astafieva, et al.
Published: (2024-04-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
by: N. G. Astafieva, et al.
Published: (2024-05-01)